首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1624375

全球蛋白质测定市场规模（按最终用户、应用、技术、产品类型、地区、范围和预测）

Global Protein Assays Market Size By End User, By Application, By Technology, By Product, By Type, By Geographic Scope And Forecast

出版日期: 2024年09月29日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

蛋白质测定市场评估，2024 年至 2031 年

蛋白质体学和基因组学研究活动的增加以及对药物发现和市场开发的重视是蛋白质检测市场的主要驱动力。据 Verified Market Research 分析师称，蛋白质检测市场规模预计在 2023 年超过 25 亿美元，到 2031 年将达到 52.5 亿美元。

全球对各种疾病新药的需求推动了药物研发工作，并且需要使用蛋白质测定法进行蛋白质测量、活性分析和验证，从而促进市场成长。由于对新药的需求激增，预计 2024 年至 2031 年期间市场复合年增长率为 9.7%。

蛋白质测定市场定义/概述

蛋白质测定是用于量化和分析生物材料中蛋白质的浓度、结构和功能的技术。这些测试在许多科学领域都很重要，包括生物化学、分子生物学和医学研究。蛋白质测定具有广泛的应用，包括药物开发、临床诊断、生物标记识别和蛋白质纯化。

此外，在药物研发中，蛋白质测定用于透过评估候选药物与目标蛋白质的相互作用来评估其功效。在临床诊断中，蛋白质测定对于检测有助于诊断疾病或评估治疗效果的特定生物标记非常重要。

研发活动的增加将如何影响市场？

生物技术和製药业的研发活动显着成长，特别是在药物发现、开发和製造程序方面。这些研发活动中使用蛋白质测定来进行蛋白质定量、药物测试以及确定药物的功效和安全性。研发支出的增加，加上对创新疗法和个人化医疗的需求的增加，是蛋白质检测市场的主要驱动力。

更为精细、灵敏和快速的蛋白质测定方法的开发将提高蛋白质分析的效率。比色法、萤光法和发光法已经发展，可以提供更准确、更可靠的蛋白质含量测量。自动化和小型化是技术突破的两个例子，它们可以实现高通量筛选，同时减少蛋白质分析的时间和成本。这些技术进步正在增强蛋白质检测在各种应用中的吸引力和适用性，有助于扩大市场。

基因组学、蛋白质组学和个人化医疗等生命科学领域的全球成长正在增加对蛋白质测定的需求。瞭解和分析蛋白质对于这些领域的许多应用至关重要，包括生物标记的发现、疾病研究和治疗开发。

此外，慢性病发病率的增加以及对新诊断和治疗方法的需求正在推动临床研究和诊断对蛋白质检测的需求，从而扩大市场。

阻碍蛋白质测定市场成长的主要障碍是什么？

由于不同测试平台和方法缺乏标准化，蛋白质检测市场的发展受到阻碍，导致结果的可重复性和可比性问题。这种差异在需要精确测量的研究和临床环境中尤其明显，导致采用缓慢。

蛋白质检测的开发和商业化，特别是用于诊断和治疗应用的检测，受到美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等机构制定的严格监管标准的约束。以这种方式与监管机构打交道既费时又费钱，尤其给新进者、中小型企业带来沉重的负担。此外，不断遵守不断变化的规范和标准会在资源和技能方面造成障碍，从而限制市场扩张。

Increased research activity in proteomics and genomics, as well as a greater emphasis on medication discovery and development, are significant drivers fueling the Protein Assays Market. According to the analyst from Verified Market Research, the Protein Assays Market is estimated to reach a valuation of USD 5.25 Billion by 2031, surpassing a revenue of aroundUSD 2.5 Billion valued in 2023.

The global desire for new medications for a wide range of diseases is driving drug research and development efforts, demanding the usage of protein assays for protein measurement, activity analysis, and validation, consequently increasing market growth. This surge in demand for new drugs enables the market to grow at aCAGR of 9.7% from 2024 to 2031.

Protein Assays Market: Definition/ Overview

Protein assays are techniques for quantifying and analyzing the concentration, structure, and function of proteins in a biological material. These tests are critical in many scientific areas, including biochemistry, molecular biology, and medical research. Protein assays have a wide range of applications, including drug development, clinical diagnostics, biomarker identification, and protein purification.

Furthermore, in drug discovery, protein assays are used to evaluate the efficacy of putative drug candidates by evaluating their interactions with target proteins. Protein assays are important in clinical diagnostics because they detect specific biomarkers that help diagnose diseases and evaluate therapy responses.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How do the Increasing Research and Development Activities Influence the Market?

There is tremendous growth in research and development (R&D) activity in the biotechnology and pharmaceutical industries, particularly in medication discovery, development, and manufacturing procedures. Protein assays are used in these R&D operations to quantify proteins, test drugs, and determine the efficacy and safety of pharmaceutical goods. Increased R&D expenditure, combined with increased demand for innovative therapies and personalized medicine, is a primary driver of the Protein Assays Market.

The development of more sophisticated, sensitive, and faster protein assay methods improves the efficiency of protein analysis. Colorimetric, fluorometric, and luminescence assays have evolved to provide more accurate and reliable measures of protein content. Automation and miniaturization are two examples of technological breakthroughs that enable high-throughput screening while reducing the time and expense involved with protein analysis. These technical advancements increase the appeal and applicability of protein assays in a variety of applications, hence boosting market expansion.

The global growth of the life sciences sector, which includes genomics, proteomics, and personalized medicine, has increased demand for protein assays. Understanding and analyzing proteins is critical for many applications in these domains, including biomarker discovery, disease research, and treatment development.

Furthermore, the growing frequency of chronic diseases, as well as the need for new diagnoses and therapies, drive demand for protein assays in clinical research and diagnostics, resulting in market expansion.

Which are the Primary Obstacles Hindering the Growth of Protein Assays Market?

The absence of standardization across different test platforms and methods poses a significant difficulty in the Protein Assays Market, resulting in problems with reproducibility and comparability of results. This discrepancy is especially significant in research and clinical contexts, where precise measurements are required, and causing delayed adoption.

Protein assay development and commercialization, particularly for diagnostic or therapeutic uses, are subject to severe regulatory standards imposed by agencies such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Navigating these regulatory routes is time-consuming and expensive, particularly for newer and smaller businesses. Also, ongoing compliance with changing norms and standards presents a barrier in terms of both resources and skill, limiting market expansion.

Category-Wise Acumens

How do Ease of Use and Convenience Contribute to the Sales of Dye-binding Assays?

According to VMR analysis, the dye-binding assays segment is estimated to hold the largest market share in the type segment during the forecast period. Dye-binding assays provide a simple and rapid method for protein quantification that may be carried out in most laboratory settings without the use of costly equipment or highly specialized skills. They are a popular choice among researchers and technicians due to their simplicity and accessibility, especially for routine analysis and applications requiring high throughput.

Economic factors play an important influence in the use of certain tests in research and industrial applications. Dye-binding assays are often less expensive than other types of protein assays, making them an appealing alternative for labs with tight budgets or those who need to run a large number of assays regularly. The decreased cost per test enables broader application in a variety of settings, ranging from academic research to industrial quality control.

Furthermore, dye-binding assays and other leading segments are often compatible with a wide variety of samples, such as cell lysates, serum, and recombinant proteins. This versatility allows them to be used in a wide range of research domains and applications, from fundamental biological research to medication discovery and development. Furthermore, their capacity to adapt and integrate with current protocols and equipment adds to their widespread adoption and commercial dominance.

What factors drive the protein assays for Drug Discovery and Development?

The drug discovery and development segment is estimated to grow at the highest CAGR in the Protein Assays Market during the forecast period. The pharmaceutical and biotechnology businesses are increasing their investment in R&D activities. This is in reaction to the rising demand for new therapeutic medications to meet unmet medical requirements such as chronic diseases, cancer, and rare disorders. Protein assays play an important part in the drug development process, from initial screening to target selection and validation, making them must-have tools in R&D laboratories.

Furthermore, there is a growing emphasis on personalized medicine, which seeks to customize treatments to specific patient profiles such as genetic makeup and protein expression patterns. Protein assays are critical for discovering and quantifying biomarkers that might predict medication response or toxicity, hence facilitating the creation of more tailored and effective treatments. This personalized approach to drug development is primarily reliant on powerful protein analysis techniques, emphasizing the significance of the Protein Assays Market in drug discovery and development.

Country/Region-wise Acumens

How does a Strong Biotechnology Sector Influence the Market Dynamics of North America?

According to VMR analysts, North America is estimated to dominate the Protein Assays Market during the forecast period. North America is home to some of the world's largest and most important biotechnology and pharmaceutical businesses, which make significant investments in research and development (R&D). This strong R&D environment is bolstered by significant investment in innovation, resulting in high demand for protein assays in drug discovery, development procedures, and disease research. The existence of these industrial titans, together with a thriving ecosystem of smaller biotech firms and start-ups, fuels the demand for protein assays to support their substantial research operations.

Furthermore, the region has a sophisticated research infrastructure, including world-class universities, research institutions, and clinical research organizations (CROs). These organizations frequently interact with the biotech and pharmaceutical industries on research projects, increasing demand for protein assays.

Will High Healthcare Expenditure in China and India Prove Fruitful for the Asia Pacific Market?

Asia Pacific region is estimated to be the most opportunistic region for the Protein Assays Market during the forecast period. Countries in the Asia Pacific, such as China, India, South Korea, and Singapore, are experiencing significant economic growth, which has resulted in increasing healthcare spending and investment in life sciences research. Governments and private sector players are making major investments in healthcare infrastructure, research centers, and biotechnology parks, creating a favorable environment for the Protein Assays Market to grow. This funding aims to improve healthcare outcomes and promote innovation in drug research and diagnostics, where protein assays play an important role.

Furthermore, academic and clinical research are becoming increasingly important in the Asia Pacific area, with countries aspiring to become hubs of innovation and scientific discovery. This includes major investments in higher education and research institutions, as well as efforts to develop relationships among academics, government, and industry. The emphasis on research areas such as cancer, infectious diseases, and genetics, where protein analysis is critical, is resulting in an expanded use of protein assays.

Competitive Landscape

The competitive landscape of the Protein Assays Market is defined by a dynamic and innovative environment in which entities compete for prominence through technological breakthroughs, product portfolio expansion, and penetration into emerging markets.

Some of the prominent players operating in the Protein Assays Market include:

Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, Danaher Corporation, Cell Signaling Technology, Abcam plc, PerkinElmer Inc., QIAGEN, Lonza, Bio-Techne, BioVision Inc, Geno Technology Inc.

Latest Developments

In October 2023, Thermo Fisher Scientific introduced their new "QuantiFluor ONE Protein Assay". This assay is intended to provide high sensitivity and a large dynamic range for protein measurement in a variety of biological samples.

In September 2023, Merck KGaA collaborated with "AIVITA Animal Health" to develop and commercialize a novel blood test for the early diagnosis of canine parvovirus. This test utilizes protein assay technology for a faster and more accurate diagnosis.

In August 2023, Bio-Rad Laboratories announced its new "Chemiluminescent Western Blot Detection Kits". These kits provide enhanced sensitivity and lower background noise for Western blot analysis, a crucial protein test technique.

1 INTRODUCTION OF GLOBAL PROTEIN ASSAYS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PROTEIN ASSAYS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PROTEIN ASSAYS MARKET, BY TYPE

5.1 Overview
5.2 Dye-binding Assays
5.3 Copper-ion-based Assays
5.4 Test Strip-based Assays
5.5 Others

6 GLOBAL PROTEIN ASSAYS MARKET, BY PRODUCT

6.1 Overview
6.2 Reagents
6.3 Kits
6.4 Instruments & Accessories

7 GLOBAL PROTEIN ASSAYS MARKET, BY TECHNOLOGY

7.1 Overview
7.2 Colorimetric-based Protein Assays
7.3 Fluorescence-based Protein Assays
7.4 Absorbance-based Protein Assays

8 GLOBAL PROTEIN ASSAYS MARKET, BY APPLICATION

8.1 Overview
8.2 Drug Discovery and Development
8.3 Disease Diagnosis
8.4 Others

9 GLOBAL PROTEIN ASSAYS MARKET, BY END-USER

9.1 Overview
9.2 Pharmaceutical & Biotechnology Companies
9.3 Hospitals
9.4 Clinical Laboratories
9.5 Academic Institutes
9.6 Others

10 GLOBAL PROTEIN ASSAYS MARKET, BY GEOGRAPHY

10.1 Overview
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 U.K.
- 10.3.3 France
- 10.3.4 Rest of Europe
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Rest of Asia Pacific
10.5 Rest of the World
- 10.5.1 Latin America
- 10.5.2 Middle East & Africa

11 GLOBAL PROTEIN ASSAYS MARKET COMPETITIVE LANDSCAPE

11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES

12.1 Bio-Rad Laboratories
- 12.1.1 Overview
- 12.1.2 Financial Performance
- 12.1.3 Product Outlook
- 12.1.4 Key Developments
12.2 Thermo Fisher Scientific
- 12.2.1 Overview
- 12.2.2 Financial Performance
- 12.2.3 Product Outlook
- 12.2.4 Key Developments
12.3 Merck KGaA
- 12.3.1 Overview
- 12.3.2 Financial Performance
- 12.3.3 Product Outlook
- 12.3.4 Key Developments
12.4 Danaher Corporation
- 12.4.1 Overview
- 12.4.2 Financial Performance
- 12.4.3 Product Outlook
- 12.4.4 Key Developments
12.5 Cell Signaling Technology
- 12.5.1 Overview
- 12.5.2 Financial Performance
- 12.5.3 Product Outlook
- 12.5.4 Key Developments
12.6 Abcam plc
- 12.6.1 Overview
- 12.6.2 Financial Performance
- 12.6.3 Product Outlook
- 12.6.4 Key Developments
12.7 PerkinElmer Inc.
- 12.7.1 Overview
- 12.7.2 Financial Performance
- 12.7.3 Product Outlook
- 12.7.4 Key Developments
12.8 QIAGEN
- 12.8.1 Overview
- 12.8.2 Financial Performance
- 12.8.3 Product Outlook
- 12.8.4 Key Developments
12.9 Lonza
- 12.9.1 Overview
- 12.9.2 Financial Performance
- 12.9.3 Product Outlook
- 12.9.4 Key Developments
12.10 Bio-Techne
- 12.10.1 Overview
- 12.10.2 Financial Performance
- 12.10.3 Product Outlook
- 12.10.4 Key Developments